Hormones |
Estrogen |
downregulate |
by upregulating CXCL12 and CXCR4 expression |
13-15, 17, 29, 30
|
upregulate |
by promoting the expression of EIG121 |
28, 31
|
Progestogen |
upregulate |
impairing activation of AKT, ERK1/2, and mTOR |
28, 31
|
downregulate |
PR dependent |
14 |
FSH |
upregulate |
partly through activating the phosphorylation of Smad2/ Smad3 via transforming growth factor beta (TGFβ) |
33 |
Androgen |
negatively correlated |
increased androgen availability in PCOS is associated with downregulation of endometrial autophagy |
34 |
Dexamethasone |
downregulate |
significantly reduced autophagy in the day 1 pregnant mice uterus which may be related to inflammatory response |
14 |
Metabolism and Metabolites |
Palmitic acid |
downregulate |
defects in autophagy caused by palmitic acid may contribute to impaired decidualization |
16 |
Indoleacrylic acid (IAA) |
biphasic effect |
inhibiting autophagy with doses <1 mmol/L but inducing at 1 mmol/L; autophagy caused by 1 mmol/L IAA coule be reversed by the concomitant treatment of tryptophan (100 mumol/L) |
37 |
Phosphocholine |
upregulate |
in a dose-dependent manner |
37 |
lyso-platelet-activating factor-16(lyso-PAF) |
upregulate |
in a dose-dependent manner |
37 |
retinoic acid |
upregulate |
/ |
38 |
Folate acid |
|
/ |
35 |
calcium |
downregulate |
calcium chelator induce an early onset of autophagy through AMPK/mTORC1 pathway under oxidative stress |
26 |
iron |
upregulate |
by the activation of AKT and MAPK pathway |
41 |
hypoxia |
upregulate |
through HIF-1α |
22, 23
|
Oxidative stress |
upregulate |
by itself and/or a positive feedback with heme oxygenase-1(HO-1), ROS, and other down-stream responses |
21, 41-43
|
Enzymes, inhibitor and drugs |
SGK1 |
upregulate |
associated to the induction of endoplasmic reticulum stress |
48 |
Liraglutide |
upregulate |
may be related to the AMPK phosphorylation |
49 |
Bortezomib |
downregulate |
inducing ERK phosphorylation and inhibiting protein degradation in lysosomes |
50 |
MHY2256 |
upregulate |
p53 acetylation |
51 |
RAD001 |
upregulate |
downregulation of AKT/mTOR phosphorylation |
52, 53
|
Rapamycin |
upregulate |
binds to FKBP1A/FKBP12 and inhibits mTORC1 |
30, 58
|
Metformin |
upregulate |
inducing autophagy through CEBPD upregulation or AMPKα |
63, 64
|
Sorafenib |
upregulate |
through a MAPK/JNK-dependent mechanism |
67 |
Isoliquiritigenin (ISL) |
upregulate |
By activating the extracellular signal regulated kinase signaling pathway |
71 |
Itraconazole |
upregulate |
inhibit the expression of mTOR signaling components |
70 |
Protopanaxadiol |
upregulate |
via AMPK/JNK phosphorylation |
30, 72
|
PDCD4 |
downregulate |
may be related to NF-kappaB/MMP2/MMP9 signal pathway |
68 |
Cisplatin |
upregulate |
via the PI3K/AKT/mTOR signalling pathway |
69 |
Others |
miR-101-3p |
upregulate |
by downregulating the expression of Enhancer of zeste homolog 2 (EZH2) |
73 |
miR-210 |
upregulate |
partly by inhibiting the Bcl-2 expression |
76 |
MiR-218 |
downregulate |
by directly bind to the 3'-UTR of HMGB1 gene |
77 |
Lnc-RNA HOTAIR |
downregulate |
by influencing Beclin-1, MDR, and P-gp expression |
78 |
lncRNA-MALAT1 |
upregulate |
/ |
79 |
DNA mismatch repair (MMR) |
upregulate |
via signal transferred by p53 |
80 |